Navigation Links
ULURU Inc. Reports Third Quarter 2013 Financial Results
Date:11/15/2013

ADDISON, Texas, Nov. 15, 2013 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR) today announced its financial results for the third quarter ended September 30, 2013 and provided a review of its operating activities.

During the third quarter, continued progress was made towards the expansion of commercialization of Altrazeal® in international markets:

  • Orders of Altrazeal® were shipped to five new markets in September and October 2013; the Czech Republic, Slovakia, South Africa, Croatia and Slovenia;
  • Production of Altrazeal® has been initiated in the fourth quarter 2013 for eight additional markets;
  • In September 2013, we executed a License and Supply Agreement with Altrazeal AG to market Altrazeal® in several new territories, to include Africa (markets not already licensed), Latin America, the Commonwealth of Independent States, Georgia, Ukraine, and Turkmenistan. Under the terms of the agreement with Altrazeal AG, we received an up-front licensing payment, will receive certain royalties on product sales within the territories, and will supply Altrazeal® at an agreed upon price; and
  • Since the beginning of the third quarter 2013, we announced the further expansion of the Altrazeal® international marketing network to include 16 additional countries including, Scandinavia, Finland, South Africa, Czech Republic, Slovakia, Portugal, Croatia, and Slovenia.
  • Other noteworthy events include the Company's capital structure being simplified through the redemption of all outstanding shares of preferred stock. In addition, the results of our randomized study were published in the peer reviewed International Wound Journal.

    Commenting on the business activities, Kerry P. Gray, President and CEO, stated, "Outstanding progress has been made on numerous fronts during the past quarter. We believe we are significantly ahead of schedul
    '/>"/>

    SOURCE ULURU Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. ULURU Inc. Announces Conference Call To Discuss Financial Results For The Third Quarter Ended September 30, 2013
    2. ULURU Inc. Completes Redemption Of Preferred Stock
    3. ULURU Inc. Reports Second Quarter 2013 Financial Results
    4. ULURU Inc. Announces Conference Call To Discuss Financial Results For The Second Quarter Ended June 30, 2013
    5. ULURU Inc. Reports First Quarter 2013 Financial Results
    6. ULURU Inc. Announces Conference Call To Discuss Financial Results For The First Quarter Ended March 31, 2013
    7. ULURU Inc. Reports Financial Results For Fourth Quarter And Year Ending December 31, 2012
    8. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2012 and to Provide a Business Update
    9. ULURU Inc. Business Update And Outlook
    10. ULURU Inc. Announces Closing Of $440,000 Private Placement
    11. ULURU Inc. Reports Third Quarter 2012 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/31/2015)... 31, 2015  DICOM Grid,  the #1 medical ... was recognized as a semifinalist for a Minnie ... The awards are sponsored by Auntminnie.com, a comprehensive ... the medical imaging industry.  Since 1999, the "Minnies" ... acknowledge the contributions of their peers. Nominations are ...
    (Date:8/31/2015)... -- Thousands of people will peacefully demonstrate their frustration ... epidemic at dozens of rallies across the country today. ... the United States has experienced skyrocketing rates ... heroin, yet the President has never once spoken publicly ... to President Obama , rally organizers compared his failure ...
    (Date:8/31/2015)... The Wolf Administration today announced 289 drug ... State Police and local police departments have ... Heroin and opioid overdose are the leading cause of ... more individuals than those involved in fatal motor vehicle ... drug overdose. " Pennsylvania ...
    Breaking Medicine Technology:DG Suite Nabs "Minnies" Nomination for "Best New Radiology Software" 2Obama Administration's Neglect of Opioid Crisis Prompts Rallies in Many States 2Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 2Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 3
    ... Business Leaders, European Schoolnet and the European ... science and maths European business leaders and ... to inspire students to study science at university - ... is to recover and flourish by 2020. ...
    ... CAMBRIDGE, Mass., Dec. 13, 2011  Merrimack Pharmaceuticals, Inc. ... dosed in a Phase 1 clinical study combining ... ErbB3, with cetuximab (Erbitux®) and irinotecan (Camptosar®) in ... http://photos.prnewswire.com/prnh/20100913/NE63515LOGO ) The Phase 1 ...
    Cached Medicine Technology:No European Scientists Left by 2020? 2No European Scientists Left by 2020? 3No European Scientists Left by 2020? 4Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121 in Combination with Cetuximab and Irinotecan in Patients with Advanced Cancers 2
    (Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... is a one-day event geared to patients and family members, medical professionals, ... local and regional mesothelioma experts. The conference is a collaborative effort between the ...
    (Date:8/31/2015)... , ... August 31, 2015 , ... The Bay ... to Veterans residing across southwest Florida by hiring more doctors and nurses and expanding ... of expanded services. , In early July, Dr. Anthony Jabre was selected to lead ...
    (Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... Replacement Surgery Program at Monmouth, was one of the first doctors in the ... results of this new approach have been impressive: faster recovery, decreased immediate and ...
    (Date:8/31/2015)... ... August 31, 2015 , ... Dr. Stewart Shofner ... be prevented during Amblyopia Awareness Month. Only a comprehensive eye examination can diagnose amblyopia. ... cause of visual impairment among children, affecting approximately 2 to 3 out of every ...
    (Date:8/31/2015)... ... 31, 2015 , ... The dental implant and prosthetic market in the U.S. ... Dentistry. (See Press Room ) More than 30 million Americans are missing all ... increasing demand for dental implants, the National Association of Dental Laboratories (NADL) created the ...
    Breaking Medicine News(10 mins):Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 3Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 2Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 2Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 4Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 3Health News:Dental Association Raises Awareness as Implant Industry Grows 2Health News:Dental Association Raises Awareness as Implant Industry Grows 3Health News:Dental Association Raises Awareness as Implant Industry Grows 4
    ... Technology Studies (InHealth) has awarded $1.7 million in grants ... Hopkins University, Northwestern University, Medical College of Georgia, Tufts ... funding allows scientists to examine the economic and social ... diseases and chronic medical conditions. , Researchers ...
    ... Ribbon Week Will Educate Parents about Prescription,Drug Abuse, ... designated Monday, October 27th as the first "Lock Your ... Week from October 27-31, to,raise awareness and provide parents ... Statistics show that over 3 million teens in the ...
    ... In light of,recent events impacting the global ... ), a publicly traded special purpose,acquisition company with ... assets being held in trust. As of October ... account at Morgan Stanley, with,Continental Transfer & Trust ...
    ... NEW YORK, Oct. 14 On the eve of ... a Call for,Endorsement of National Latino AIDS Awareness Day ... the commitment of the future President of,the United States ... of,Hispanics throughout the United States and Puerto Rico," stated ...
    ... John Price, an Influential ... for More Than 50 Years, PLEASANT HILL, Calif., Oct. 14 ... Gala on Friday, October 17, 2008 at,the Diablo Country Club located ... of community service the Y has provided,throughout Contra Costa County. One ...
    ... AMSTERDAM, Netherlands, Oct. 14 Doctors in,the Netherlands ... VAR ) to treat four early stage ... among the world,s first treatments of their kind. ... plan to replace,conventional stereotactic radiotherapy treatments with RapidArc ...
    Cached Medicine News:Health News:InHealth awards grants to study impact of medical diagnostics and devices on patients, health care 2Health News:InHealth awards grants to study impact of medical diagnostics and devices on patients, health care 3Health News:InHealth awards grants to study impact of medical diagnostics and devices on patients, health care 4Health News:National Family Partnership Designates October 27th 'Lock Your Meds' Day 2Health News:National Family Partnership Designates October 27th 'Lock Your Meds' Day 3Health News:Apex Bioventures Announces Trust Investment Details 2Health News:The Latino Commission on AIDS Call on Presidential Candidates to Honor National Latino AIDS Awareness Day on October 15 2Health News:Mt. Diablo Region YMCA to Celebrate 50 Years of Community Service at 28th Annual Boosters Gala on October 17, 2008 2Health News:Clinicians in Netherlands Treat Lung Cancer Patients Using New RapidArc Radiotherapy Technology from Varian Medical Systems 2Health News:Clinicians in Netherlands Treat Lung Cancer Patients Using New RapidArc Radiotherapy Technology from Varian Medical Systems 3
    ... new OTI-Scan 1000 is the most advanced ... B/A-scan system operates with a single Macintosh ... B-scans with a streamlined internal probe rotator. ... newly designed. The UltraFast 12 MHz B-probe ...
    ... The B5500 is a sensitive B-scan system ... the axial length of both eyes differ by ... ocular abnormality must be suspected. The B5500 enables ... setting up a water bath or inserting shells ...
    ... A-scan and B-scan system, providing accurate and ... high frequency, low noise probe and fast ... upon application of the probe along the ... length of both eyes differ by more ...
    ... The CineScan A/B represent a true breakthrough ... image with technology and diagnostic capability previously ... the vitreous. Adjust the gain up to ... be invisible at a standard 90db setting ...
    Medicine Products: